PurposeTo outline the association between race/ethnicity and poverty status and perceived anxiety and depressive symptomologies among BRCA1/2-positive United States (US) women to identify high-risk groups of mutation carriers from medically underserved backgrounds. Methods 211 BRCA1/2-positive women from medically underserved backgrounds were recruited through national Facebook support groups and completed an online survey. Adjusted odds ratios (aOR) and 95% con dence intervals (CIs) were estimated using multivariable logistic regression for associations between race/ethnicity, poverty status, and self-reported moderate-to-severe anxiety and depressive symptoms.
ResultsWomen ranged in age (18-75, M = 39.5, SD = 10.6). Most women were non-Hispanic white (NHW) (67.2%) and were not impoverished (76.7%). Hispanic women with BRCA1/2 mutations were 6.11 times more likely to report moderate-to-severe anxiety (95% CI, 2.16-17.2, p = 0.001) and 4.28 times more likely to report moderate-to-severe depressive symptoms (95% CI, 1.98-9.60, p = < 0.001) than NHW women with BRCA1/2. Associations were not statistically signi cant among other minority women. Women living in poverty were signi cantly less likely to report moderate-to-severe depressive symptoms than women not in poverty (aOR, 0.42, 95% CI, 0.18-0.95, p = 0.04).
ConclusionHispanic women with BRCA1/2 mutations from medically underserved backgrounds are an important population at increased risk for worse anxiety and depressive symptomology. Our ndings among Hispanic women with BRCA1/2 mutations add to the growing body of literature focused on ethnic disparities experienced across the cancer control continuum. impoverished women. Furthermore, the impact on mental health among BRCA1/2-positive women from racial/ethnic and impoverished groups remains relatively unknown, as past literature has targeted racial/ethnic minority women from one location due to di culty in recruitment [29,30].Objectives. The current study aims to outline the association between race/ethnicity and poverty status and perceived anxiety and depressive symptomologies among BRCA1/2-positive US women to identify high-risk groups of mutation carriers from medically underserved backgrounds. Women with BRCA1/2 mutations may experience adverse mental health symptomologies related to their mutations and ongoing care, and we hypothesize that racial/ethnic minority and impoverished women may face an even more heightened threat.
Methods
Study Design & Sample